Groupon founder and Chair Eric Lefkofsky has recently been looking for new and innovative ways of using the technology that is changing the world around us for the better. The technology investment specialist has built an impressive personal fortune rated at around $1.7 billion for the many different technology based businesses he has created over the years and has now looked to invest some of this fortune in his new company, Tempus, which is the latest bid by an entrepreneur and philanthropist to overcome the medical issue of cancer in its many different forms.
Over the course of his career, Eric Lefkofsky, has built a number of powerful technology companies, including the Echo Global Logistics Company that has built upon a deep understanding of the latest technology and opened up new ways of working as a business leader. Tempus is looking to take advantage of the lowering cost of DNA testing the company believes will have great advantages for medical professionals who are looking for answers to the serious questions posed by different forms of cancer.Eric Lefkofsky believes the development of a database of cancer patients will be of great importance to those who are looking to prolong the lives of cancer patients and even find cures for specific cancer. Tempus has also been developing software that will work hand in hand with the database of DNA samples that will provide information on which forms of treatments have proven successful for cancers identified using DNA testing.
The life of Eric Lefkofsky has seen the University of Michigan Law School graduate move into the world of technology with relative ease, particularly after the establishment of the Groupon company that has been the most successful in the career of Eric Lefkofsky.Throughout his career, Eric Lefkofsky has worked closely with his business partner Brad Keywell in a bid to identify the areas of business and industry where a product or service could have a major impact; the pair have proven successful in a number of different areas; Tempus is now the major concern of Eric Lefkofsky as he steps back from his main roles with Groupon in a bid to develop a brighter future to aid the medical industry.